[Infliximab treatment trial in a patient with neuro-Behçet's disease unresponsive to other treatments].

Kadowaki, Suguru; Matsuda, Nozomu; Moriya, Arata; Ebitani, Masahiro; Yoshihara, Akioh; Nakamura, Kouichirou; Mochizuki, Hitoshi; Ugawa, Yoshikazu

Kadowaki, Suguru; Matsuda, Nozomu; Moriya, Arata; Ebitani, Masahiro; Yoshihara, Akioh; Nakamura, Kouichirou; Mochizuki, Hitoshi; Ugawa, Yoshikazu.

Affiliation

Kadowaki S; Department of Neurology, Fukushima Medical University.

Rinsho Shinkeigaku ; 51(4): 261-6, 2011 Apr.

Article in Ja | MEDLINE | ID: mdl-21595295

Subject(s)

Antibodies, Monoclonal/administration & dosage; Behcet Syndrome/drug therapy; Adrenal Cortex Hormones; Behcet Syndrome/complications; Behcet Syndrome/diagnosis; Biomarkers/cerebrospinal fluid; Drug Administration Schedule; Hiccup/drug therapy; Hiccup/etiology; Humans; Infliximab; Interleukin-6/cerebrospinal fluid; Male; Meningitis/drug therapy; Meningitis/etiology; Methotrexate; Treatment Failure; Treatment Outcome; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Uveitis/drug therapy; Uveitis/etiology; Young Adult

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Behcet Syndrome / Antibodies, Monoclonal Type of study: Diagnostic_studies / Etiology_studies Limits: Adult / Humans / Male Language: Ja Journal: Rinsho Shinkeigaku Year: 2011 Document type: Article Country of publication: Japan

Search on Google

Add to My VHL

XML

PubMed Links